|
WO2021004885A1
|
|
Novel allergen
|
|
EP3743919A1
|
|
Method for the harmonization of assay results
|
|
CN110382718A
|
|
It is used to indicate the present or absent method of the prostate cancer in the individual with special characteristic
|
|
CA2955348A1
|
|
Novel allergen
|
|
CA2940445A1
|
|
Method for detecting a solid tumor cancer
|
|
EP3084439A1
|
|
Analysis of antibodies
|
|
AU2013349721A1
|
|
Prognostic method for individuals with prostate cancer
|
|
CA2891392A1
|
|
Method for indicating a presence or non-presence of aggressive prostate cancer
|
|
US2015094221A1
|
|
Method for Indicating the Presence or Non-Presence of Prostate Cancer
|
|
AU2013202338A1
|
|
Novel wheat allergens
|
|
AU2012309203A1
|
|
Calibration reagent and method
|
|
EP2673292A1
|
|
Wheat antigens and peptides for diagnosis of wheat induced hypersensitivity
|
|
EP2577308A1
|
|
Method for decision support in allergy diagnosis
|
|
AU2011243277A1
|
|
Novel allergen
|
|
CN102459323A
|
|
Recombinantly produced allergens
|
|
CA2744434A1
|
|
Methods, devices and kits for detecting or monitoring acute kidney injury
|
|
GB0911958D0
|
|
Improved microparticles
|
|
NZ587241A
|
|
Method, computer program product and system for enabling clinical decision support
|
|
WO2009070122A1
|
|
A novel method for assessing if symptoms in a patient are related to a hypersensitivity to a specific allergen
|
|
EP2225266A1
|
|
Novel wheat allergens
|
